178 results on '"MAGDELÉNAT H"'
Search Results
2. Quantitative Measurement of DNA Strand Breaks and Repair in γ-Irradiated Human Leukocytes from Normal and Ataxia Telangiectasia Donors
3. Caractéristiques biologiques pré– et post–traitement néo–adjuvant du cancer du sein
4. Une nouvelle thérapie ciblée avec le bortézomib, médicament oncologique de l’année 2004
5. Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer
6. Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer
7. Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay — a retrospective study
8. Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis
9. Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast
10. Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients
11. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases
12. Hommages à Pierre-Marie Martin
13. The Place of Hormone Receptors in the Elaboration of a Therapeutic stategy Against Breast Cancer
14. Estrogen and Progestin Receptors on Drill Biopsy Samples of Human Mammary Tumors
15. Prognostic value of epidermal growth factor receptor in node-positive breast cancer
16. Immunocytochemical determination of estrogen and progesterone receptors on 50 fine-needle samples of breast cancer. A prospective study including biochemical correlation and DNA flow cytometric analysis
17. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy
18. Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction
19. HER2 gene status assessment in micrometastatic cells in bone marrow (BM) of breast cancer patients by fluorescence in situ hybridization (FISH)
20. Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
21. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.
22. Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
23. Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation.
24. Plasminogen activator and progesterone receptor are correlated in human mammary tumors
25. Illegitimate Villin Transcripts in Normal Bone Marrow Precludes Detection of Colon Cancer Micrometastases
26. The Receptor and Biomarker Study Group of the EORTC
27. Is ERBB-2 A predictive marker for response to primary chemotherapy for operable breast cancer: a prospective study in a phase ii randomized trial of doxorubicin/cyclophosphamide (AC) and doxorubicin/paclitaxel (AT)
28. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-α-initiated apoptosis
29. Overexpression of PDGF receptor β in dermal fibroblasts of lymphangitic post radiotherapy relapses of breast carcinoma
30. S-phase fractions of breast cancer predict overall and post-relapse survival
31. Amélioration du contrôle de qualité pour les dosages de récepteurs stéroïdiens: analyse des distributions dans plus de 40 000 cancers primitifs du sein
32. N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma
33. In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation
34. A multiplex PCR assay for routine evaluation of deletion of the short arm of chromosome 1 in neuroblastoma
35. Prognostic Value of the S-Phase Fraction of Breast Cancers Treated by Primary Radiotherapy or Neoadjuvant Chemotherapy
36. Progesterone receptor as a more reliable prognostic parameter than estrogen receptor in patients with advanced breast cancer
37. Étude du BCM-IMx (Abbott) dans le cancer du sein. Comparaison avec CA15.3 et ACE
38. Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph-node metastasis
39. Increased cell size and Akt activation in HER-2/ neu-overexpressing invasive ductal carcinoma of the breast.
40. DNA flow cytometry applied to fine needle sampling of human breast cancer.
41. The effect of counter-ion substitution on the transport properties of polyelectrolyte solutions.
42. Electric mobility of bivalent cations in the presence of an anionic polysaccharide.
43. Correlation of Pretreatment Proliferative Activity of Breast Cancer With the Response to Cytotoxic Chemotherapy.
44. Immunoenzymetric Assay of Epidermal Growth Factor Receptor.
45. N-MYCamplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastoma
46. In vivoinduction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation
47. Pooled Analysis of uPA and PAI-1 for Prognosis in Primary Breast Cancer Patients
48. Relevance of DNA ploidy as a measure of genetic deviation: A comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer
49. Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates
50. Administration of fibroblast interferon to patients with advanced breast cancer: Possible effects on skin metastasis and on hormone receptors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.